NL-OMON27474招募中不适用
Patient Reported Outcome Measures in BRCA 1 or 2 mutation carriers
Prof. dr. J.M. HendriksHead of Dept. of SurgeryErasmus University Medical CenterRg 226P.O. 20403000 CA Rotterdam(T) 010-70312060 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
ot yet, study is ongoing
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1)> 18 years
- •2)agreement with participation
排除标准
- •1)no adequate understanding of Dutch language
- •2)time since surgery <1 year,
研究者
相似试验
尚未招募
不适用
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer OvaryOvarian CancerNCT06304922Assiut University45
已完成
不适用
Prevalence of BRCA in Patients With Ovarian CancerBRCA StatusOvarian CancerNCT02222883AGO Research GmbH530
已完成
不适用
BRCA and NACT in TNBC PatientsTriple-Negative Breast CancerNCT05750719Fondazione Policlinico Universitario Agostino Gemelli IRCCS136
已完成
3 期
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaEssential HypertensionPrimary HypercholesterolemiaNCT05930028Boryung Pharmaceutical Co., Ltd148
终止
不适用
Role of Early Versus Late Switch to Lapatinib-CapecitabineCancerNCT01357863GlaxoSmithKline3